Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1985 Oct;52(4):633–636. doi: 10.1038/bjc.1985.238

Rapid fluorometric detection of drug resistant tumour cells.

A deFazio, M H Tattersall
PMCID: PMC1977247  PMID: 3904800

Full text

PDF
633

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albertini R. J., Castle K. L., Borcherding W. R. T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood. Proc Natl Acad Sci U S A. 1982 Nov;79(21):6617–6621. doi: 10.1073/pnas.79.21.6617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cifone M. A., Fidler I. J. Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6949–6952. doi: 10.1073/pnas.78.11.6949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dempsey J. L., Morley A. A. Evidence that thioguanine-resistant lymphocytes detected by autoradiography are mutant cells. Mutat Res. 1983 Feb;119(2):203–211. doi: 10.1016/0165-7992(83)90130-6. [DOI] [PubMed] [Google Scholar]
  4. Dolbeare F., Gratzner H., Pallavicini M. G., Gray J. W. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5573–5577. doi: 10.1073/pnas.80.18.5573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. ERLANGER B. F., BEISER S. M. ANTIBODIES SPECIFIC FOR RIBONUCLEOSIDES AND RIBONUCLEOTIDES AND THEIR REACTION WITH DNA. Proc Natl Acad Sci U S A. 1964 Jul;52:68–74. doi: 10.1073/pnas.52.1.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Elmore E., Kakunaga T., Barrett J. C. Comparison of spontaneous mutation rates of normal and chemically transformed human skin fibroblasts. Cancer Res. 1983 Apr;43(4):1650–1655. [PubMed] [Google Scholar]
  7. Goldie J. H., Coldman A. J. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1727–1733. [PubMed] [Google Scholar]
  8. Gratzner H. G. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science. 1982 Oct 29;218(4571):474–475. doi: 10.1126/science.7123245. [DOI] [PubMed] [Google Scholar]
  9. Hamburger A. W., Salmon S. E., Kim M. B., Trent J. M., Soehnlen B. J., Alberts D. S., Schmidt H. J. Direct cloning of human ovarian carcinoma cells in agar. Cancer Res. 1978 Oct;38(10):3438–3444. [PubMed] [Google Scholar]
  10. Irr J. D., Snee R. D. A statistical method for analysis of mouse lymphoma L5178Y cell TK locus forward mutation assay. Comparison of results among three laboratories. Mutat Res. 1982 Oct;97(5):371–392. doi: 10.1016/0165-1161(82)90004-8. [DOI] [PubMed] [Google Scholar]
  11. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  12. Li A. P., Shimizu R. W. A modified agar assay for the quantitation of mutation at the hypoxanthine guanine phosphoribosyl transferase gene locus in Chinese hamster ovary cells. Mutat Res. 1983 Nov;111(3):365–370. doi: 10.1016/0027-5107(83)90033-7. [DOI] [PubMed] [Google Scholar]
  13. Morley A. A., Trainor K. J., Seshadri R., Ryall R. G. Measurement of in vivo mutations in human lymphocytes. Nature. 1983 Mar 10;302(5904):155–156. doi: 10.1038/302155a0. [DOI] [PubMed] [Google Scholar]
  14. Morstyn G., Hsu S. M., Kinsella T., Gratzner H., Russo A., Mitchell J. B. Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody. J Clin Invest. 1983 Nov;72(5):1844–1850. doi: 10.1172/JCI111145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ochi T., Ohsawa M., Noda K., Umeda M. Improvement in recovery of 6-thioguanine-resistant mutants by the use of inhibitors of metabolic cooperation in in vitro mutagenesis assay. Jpn J Exp Med. 1982 Dec;52(6):291–295. [PubMed] [Google Scholar]
  16. Shulman M., Wilde C. D., Köhler G. A better cell line for making hybridomas secreting specific antibodies. Nature. 1978 Nov 16;276(5685):269–270. doi: 10.1038/276269a0. [DOI] [PubMed] [Google Scholar]
  17. Stewart C. C., Steinkamp J. A. Quantitation of cell concentration using the flow cytometer. Cytometry. 1982 Jan;2(4):238–243. doi: 10.1002/cyto.990020407. [DOI] [PubMed] [Google Scholar]
  18. Strauss G. H., Albertini R. J. Enumeration of 6-thioguanine-resistant peripheral blood lymphocytes in man as a potential test for somatic cell mutations arising in vivo. Mutat Res. 1979 Jul;61(2):353–379. doi: 10.1016/0027-5107(79)90140-4. [DOI] [PubMed] [Google Scholar]
  19. Voller A., Bartlett A., Bidwell D. E. Enzyme immunoassays with special reference to ELISA techniques. J Clin Pathol. 1978 Jun;31(6):507–520. doi: 10.1136/jcp.31.6.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Waddell D., Ullman B. Characterization of a cultured human T-cell line with genetically altered ribonucleotide reductase activity. Model for immunodeficiency. J Biol Chem. 1983 Apr 10;258(7):4226–4231. [PubMed] [Google Scholar]
  21. Warren S. T., Schultz R. A., Chang C. C., Wade M. H., Trosko J. E. Elevated spontaneous mutation rate in Bloom syndrome fibroblasts. Proc Natl Acad Sci U S A. 1981 May;78(5):3133–3137. doi: 10.1073/pnas.78.5.3133. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES